Delayed Administration of Recombinant Plasma Gelsolin Improves Survival in a Murine Model of Severe Influenza
F1000Research - United Kingdom
doi 10.12688/f1000research.21082.2
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 21, 2020
Authors
Publisher
F1000 Research Ltd